Assay ID | Title | Year | Journal | Article |
AID389464 | Antitrypanosomal activity against Trypanosoma brucei rhodesiense STIB 900 infected acute mouse model assessed as survival time at 1 mg/kg, ip administered daily for 4 days | 2008 | Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
| Synthesis and antiprotozoal activity of cationic 2-phenylbenzofurans. |
AID389454 | Antileishmanial activity against Leishmania donovani MHOM/SD/62/1S-CL2D axenic amastigotes | 2008 | Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
| Synthesis and antiprotozoal activity of cationic 2-phenylbenzofurans. |
AID1132857 | Anticoagulant activity in human plasma assessed as prolongation of partial thromboplastin time at 10'-5 M incubated for 30 secs (Rvb = 59 +/- 5.4 secs) | 1978 | Journal of medicinal chemistry, Jul, Volume: 21, Issue:7
| Diarylamidine derivatives with one or both of the aryl moieties consisting of an indole or indole-like ring. Inhibitors of arginine-specific esteroproteases. |
AID1132852 | Competitive reversible inhibition of bovine trypsin using alpha-N-benzoyl-DL-arginine-p-nitroanilide hydrochloride as substrate after 15 to 30 mins by Michaelis-Menten plot analysis | 1978 | Journal of medicinal chemistry, Jul, Volume: 21, Issue:7
| Diarylamidine derivatives with one or both of the aryl moieties consisting of an indole or indole-like ring. Inhibitors of arginine-specific esteroproteases. |
AID580533 | Antimicrobial activity against Bacillus anthracis Sterne spores by broth microdilution method | 2009 | Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
| Novel broad-spectrum bis-(imidazolinylindole) derivatives with potent antibacterial activities against antibiotic-resistant strains. |
AID580534 | Antimicrobial activity against Bacillus anthracis Sterne vegetative cells by broth microdilution method | 2009 | Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
| Novel broad-spectrum bis-(imidazolinylindole) derivatives with potent antibacterial activities against antibiotic-resistant strains. |
AID389451 | Selectivity index, ratio of IC50 for rat L6 cells to IC50 for Trypanosoma brucei rhodesiense STIB 900 | 2008 | Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
| Synthesis and antiprotozoal activity of cationic 2-phenylbenzofurans. |
AID1132851 | Competitive reversible inhibition of bovine thrombin using alpha-N-benzoyl-DL-arginine-p-nitroanilide hydrochloride as substrate after 15 to 40 mins by Michaelis-Menten plot analysis | 1978 | Journal of medicinal chemistry, Jul, Volume: 21, Issue:7
| Diarylamidine derivatives with one or both of the aryl moieties consisting of an indole or indole-like ring. Inhibitors of arginine-specific esteroproteases. |
AID389452 | Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 | 2008 | Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
| Synthesis and antiprotozoal activity of cationic 2-phenylbenzofurans. |
AID53470 | Inhibitory dose against oncornaviral DNA polymerase activity of moloney murine leukemia virus | 1980 | Journal of medicinal chemistry, Jul, Volume: 23, Issue:7
| Diaryl amidine derivatives as oncornaviral DNA polymerase inhibitors. |
AID1132858 | Anticoagulant activity in human plasma assessed as prolongation of partial thromboplastin time at 5 x 10'-6 M incubated for 30 secs (Rvb = 59 +/- 5.4 secs) | 1978 | Journal of medicinal chemistry, Jul, Volume: 21, Issue:7
| Diarylamidine derivatives with one or both of the aryl moieties consisting of an indole or indole-like ring. Inhibitors of arginine-specific esteroproteases. |
AID389466 | Antitrypanosomal activity against Trypanosoma brucei rhodesiense STIB 900 infected acute mouse model assessed as survival time at 5 mg/kg, ip administered daily for 4 days | 2008 | Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
| Synthesis and antiprotozoal activity of cationic 2-phenylbenzofurans. |
AID389450 | Antitrypanosomal activity against Trypanosoma brucei rhodesiense STIB 900 bloodstream trypomastigotes | 2008 | Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
| Synthesis and antiprotozoal activity of cationic 2-phenylbenzofurans. |
AID389467 | Antitrypanosomal activity against Trypanosoma brucei rhodesiense STIB 900 infected acute mouse model assessed as survival time at 10 mg/kg, ip | 2008 | Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
| Synthesis and antiprotozoal activity of cationic 2-phenylbenzofurans. |
AID389453 | Selectivity index, ratio of IC50 for rat L6 cells to IC50 for chloroquine-resistant Plasmodium falciparum K1 | 2008 | Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
| Synthesis and antiprotozoal activity of cationic 2-phenylbenzofurans. |
AID1132856 | Anticoagulant activity in human plasma assessed as prolongation of partial thromboplastin time at 10'-4 M incubated for 30 secs (Rvb = 59 +/- 5.4 secs) | 1978 | Journal of medicinal chemistry, Jul, Volume: 21, Issue:7
| Diarylamidine derivatives with one or both of the aryl moieties consisting of an indole or indole-like ring. Inhibitors of arginine-specific esteroproteases. |
AID389449 | Cytotoxicity against rat L6 cells | 2008 | Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
| Synthesis and antiprotozoal activity of cationic 2-phenylbenzofurans. |
AID1132853 | Competitive reversible inhibition of porcine pancreatic kallikrein using alpha-N-benzoyl-DL-arginine-p-nitroanilide hydrochloride as substrate after 15 to 180 mins by Michaelis-Menten plot analysis | 1978 | Journal of medicinal chemistry, Jul, Volume: 21, Issue:7
| Diarylamidine derivatives with one or both of the aryl moieties consisting of an indole or indole-like ring. Inhibitors of arginine-specific esteroproteases. |
AID389455 | Selectivity index, ratio of IC50 for rat L6 cells to IC50 for Leishmania donovani MHOM/SD/62/1S-CL2D | 2008 | Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
| Synthesis and antiprotozoal activity of cationic 2-phenylbenzofurans. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |